BIOTECH WEBSITE STRATEGY, DESIGN AND DEVELOPMENT

Your science deserves to be understood.

Paragon Biosciences

•

CiRC Biosciences

•

Emalex Biosciences

•

Paragon Biosciences • CiRC Biosciences • Emalex Biosciences •

Preparing for a financing, a readout, or a company launch? I design and build biotech websites that show investors, partners, and candidates what you’re developing, how far along you are, and why it matters.

Your website is the first meeting.

Long before the first call, the people evaluating your company have formed a view from your website. If your programs, stage, and science aren’t clear at a glance, the work behind them is undersold.

I build the site that makes that first meeting count.

01 Stage and focus

Show what you’re developing, who it’s for, and where you stand.

02 Pipeline and leadership

Give investors and partners the programs, people, and milestones they’re looking for, where they expect to find them.

03 Clear paths

Show every audience where to go next: make contact, follow the science, or find a trial site.

Strategy before aesthetics.

A strong biotech website starts with your science, your company, and the people
you need to reach. Strategy comes first. Design and development follow.

Every site I build is organized around three priorities.

Selected Work

Four projects. Four audiences. One biotech network.

A selection of projects completed as part of the Maude Group creative team, spanning corporate positioning, founder storytelling, scientific communication, and patient recruitment.


Paragon Biosciences

Audience: Investors and partners

Paragon Biosciences builds and supports biotech startups across biopharmaceuticals, cell and gene therapy, synthetic biology, and AI diagnostics.

The website presents a diverse portfolio of companies through one cohesive platform.


CiRC Biosciences

Audience: Partners and supporters

CiRC Biosciences is a preclinical cell therapy company working to restore vision for people with degenerative eye diseases.

The website communicates the science, platform, and mission to partners and supporters.


D1amond Emalex Biosciences Clinical Trial

Audience: Patients and caregivers

Emalex Biosciences is advancing treatments for central nervous system disorders, including Tourette syndrome.

A recruitment microsite for the D1AMOND Phase 3 Tourette syndrome trial, translating complex clinical information into clear eligibility and enrollment guidance for patients and caregivers.

The trial has since completed.


Jeff Aronin—Biotech Entrepreneur

Audience: Founder brand

A personal website bringing together Jeff Aronin’s work as a biotech entrepreneur and investor across life sciences, healthcare innovation, and social ventures.

How an engagement works

Five steps, from first conversation to launch.

Meet your website partner.

Hi! My name is Abby, designer and developer with more than six years of experience, including over four years in agency environments, working on biotech websites across the Paragon Biosciences’ network.

I bring strategy, storytelling, design, and development together to help biotech companies communicate what they’re building and why it matters.

Let’s build the website your science deserves.

Let’s discuss what you’re preparing for and what your website needs to accomplish.